Green coffee extract Svetol® can manage weight: A review

Agro Food Industry Hi-Tech

Volumn 18, Issue 5 SUPPL., 2007, Pages 37-39

  Nardon, Karine ^a   Lemaire, Benoit ^a   Lafay, Sophie ^a  

^a Berkem Développement ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEOYLQUINIC ACIDS; CHLOROGENIC ACIDS; CLINICAL TRIAL; GLUCOSE-6-PHOSPHATASE; GREEN COFFEE BEANS; HEPATIC ENZYMES; MECHANISM OF ACTION; WEIGHT MANAGEMENT;

ISOMERS;

ENZYME INHIBITION;

EID: 36349028063     PISSN: 17226996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. W. J. Arion, W. K. Canfield, F. C.Ramos, P. W. Schindler, H. J. Burger, H. Hemmerle, G. Schubert, P. Below, and A. W. Herling, "Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase," Arch Biochem Biophys, 339:2 (1997). 315-322.
2. BERKEM Group, Svetol Technical File Vol. Revision05. Nov. 2005.
3. J. Blum, B. Lemaire, and S. Lafay, "Svetol®, a decaffeinated green coffee extract, decreases the glycemia after an oral glucose test tolerance," Nutrafoods, Submitted (2007).
4. S. Carlsson, N. Hammar, V Grill, and J. Kaprio, "Coffee consumption and risk of type 2 diabetes in Finnish twins," Int J Epidemiol, 33:3 (2004), 616-617.
5. S. O. Dellalibera, B. Lemaire, and S. Lafay, "Le Svetol®, un extrait de café vert décaféiné, induit une perte de poids et augmente le ratio masse maigre sur masse grasse chez des volontaires en surcharge pondérale," Phytothérapie. 3 (2006), 1-4.
6. H. Hemmerle, H. J. Burger, P. Below, G. Schubert, R. Rippel, P W. Schindler, E. Paulus, and A. W. Herling, "Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase," J Med Chem, 40:2 (1997), 137-145.
7. A. W. Herling, H. J. Burger, D. Schwab, H. Hemmerle, P Below, and G. Schubert, "Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6phosphatase system," Am J Physiol, 274:6 Pt 1 (1998), G1087-1093.
8. I. O. T. IOTF, "www.iotf.org, International Association for the Study of Obesity," (consulted in October 2006).
9. A. Isogawa, M. Noda, Y Takahashi. T. Kadowaki, and S. Tsugane, "Coffee consumption and risk of type 2 diabetes mellitus," Lancet, 361:9358 (2003), 703-704.
10. K. L. Johnston, M. N. Clifford, and L. M. Morgan, "Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine," Am J Clin Nutr, 78:4 (2003), 728-733.
11. S. Lafay, A. Gil-lzquierdo, C. Manach, C. Morand, C. Besson, and A. Scalbert, "Chlorogenic acid is absorbed in its intact form in the stomach of rats," J. Nutr, 136:5 (2006), 1192-1197.
12. S. Lafay, C. Henry-Vitrac, J. Merillon, and X. Vitrac, "Svetol®, a decaffeinated green coffee extract inhibits hepatic Glucose-6phosphatase, " J Agric. Food Chem., Submitted.
13. M. Monteiro, A. Farah, D. Moreira, C. Donangelo, and L. Trugo, "Chlorogenic acids are absorbed in humans," Proc. International Conference on Coffee Science (Montpellier, 2006), p. 95.
14. R. Murray, D. Granner, P. Mayes, and V. Rodwell, Biochimie de Harper, 25ème Ed, Edition De Boeck ed., Les Presse de l'Université de Laval, 2003.
15. A. Reunanen, M. Heliövaara, and K. Aho, "Coffee consumption and risk of type 2 diabetes mellitus," Lancet, 361 (2003), 702-704.
16. D. V. Rodriguez de Sotillo and M. Hadley, "Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats," J Nutr Biochem, 13:12 (2002), 717-726.
17. E. Salazar-Martinez, W. Willett, A. Ascherio, J. Manson, M. Leitzmann, M. Stampfer, and F. Hu, "Coffee consumption and risk for type 2 diabetes mellitus," Ann Intern Med, 140:1 (2004), 1-8.
18. C Simon, A. W. Herling, G. Preibisch, and H. J. Burger, "Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose6-phosphate translocase," Arch Biochem Biophys, 373:2 (2000), 418-428.
19. J. Tuomilehto, G. Hu, S. Bidel, J. Lindstrom, and P. Jousilahti, "Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women," JAMA, 291:10 (2004), 1213-1219.
20. R. van Dam and E. Feskens, "Coffee consumption and risk of type 2 diabetes mellitus," Lancet, 360:9344 (2002). 1477-1478.
21. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, "Global prevalence of diabetes," Diabetes Care, 27:5 (2004), 1047-1053.